The FDA continues to update the list of medications being recalled. ByDr. Tulsie N. PatelandDr. Sumir Shah September 25, 2019, 5:52 AM 0:13 Makers of blood-pressure medication expand their recallThe recall of Losartan is linked to a possible cancer-causing element...
A valsartan recall has been issued in 2018 due to the fact that the popular blood pressure and heart failure medication may have traces of a carcinogen. The U.S. Food and Drug Administrationissued a warningto health care professionals and patients about the voluntary recall of a number of dru...
Aurobindo Pharma USA, Inc. is voluntarily recalling around 80 lots of blood pressure medicine that could contain a substance not intended to be in the product. The substance detected is called N-nitrosodiethylamine. It’s naturally found in certain foods, drinking water, air pollution and indust...
Continue taking your medication until your health care provider provides an alternative treatment option or your pharmacist provides a replacement. Irbesartan treats high blood pressure, which is a serious medical condition. Stopping the medication could be dangerous. If your medication was recalled, foll...
While only 32% of white adults with high blood pressure have their condition under control with medication, the figure for Black Americans is even lower — 25%. Article content And it’s likely to get worse: By 2060, the number of Americans battling cardiovascular disease is e...
While only 32% of white adults with high blood pressure have their condition under control with medication, the figure for Black Americans is even lower — 25%. And it’s likely to get worse: By 2060, the number of Americans battling cardiovascular disease is expected to drastically increase....
The FDA also said that while millions of Americans take blood pressure medication, the risk of many of them developing cancer because of the NDMA exposure is fairly low. CDER toxicologists and chemists estimated that if 8,000 people took the highest valsartan dose from NDMA-affected medicines ev...
Pfizer Canada ULC is recalling all lots of Accuretic medication in 10/12.5 mg, 20/12.5 mg and 20/25 mg strengths due to the presence of a nitrosamine impurity above the acceptable level.
Of these, 52.6% women and 47.9% men had at least one indicator of hypertension (high blood pressure on examination, or taking antihypertensive medication or recalled a doctor diagnosis of high blood pressure). Among women, 50% of those with any indication of hypertension were on treatment and ...
Blood pressure variability has been considered a physiological marker of autonomic nervous system control, with short- and long-term fluctuations from intricate interactions among behavioral, environmental, neural central or reflex influences, along with other potential contributing factors. ...